| |
| |
|
| Insider
Information: |
Sanofi-Aventis |
| Relationship: |
10% Owner |
| City: |
Paris |
| State: |
I0 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
11 |
|
| Direct
Shares |
75,668,031 |
|
|
Indirect Shares
|
26,048,661 |
|
|
| Direct
Value |
$2,826,957,638 |
|
|
|
Indirect Value
|
$1,869,919,512 |
|
|
| Total
Shares |
101,716,692 |
|
|
| Total
Value |
$4,696,877,150 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
5
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
1
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -17.8%
|
-3.6%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regulus Therapeutics Inc. |
RGLS |
10% Owner |
|
0 |
2014-02-04 |
5,053,779 |
Premium* |
|
|
Humanigen Inc |
HGEN |
Former 10% owner |
2013-01-31 |
0 |
2013-01-31 |
579,030 |
Premium* |
|
|
Glycomimetics Inc |
GLYC |
10% Owner |
|
0 |
2013-11-06 |
1,193,625 |
Premium* |
|
|
Regeneron Pharmaceuticals Inc |
REGN |
|
2020-05-29 |
0 |
2020-06-09 |
279,766 |
Premium* |
|
|
Alnylam Pharmaceuticals Inc |
ALNY |
10% Owner |
|
0 |
2017-05-31 |
10,554,134 |
Premium* |
|
|
Scynexis Inc |
SCYX |
10% Owner |
|
0 |
2014-05-07 |
1,677,057 |
Premium* |
|
|
Voyager Therapeutics, Inc. |
VYGR |
Former 10% owner |
2015-11-10 |
0 |
2015-11-16 |
2,477,941 |
Premium* |
|
|
Fulcrum Therapeutics, Inc. |
FULC |
10% Owner |
2019-07-22 |
0 |
2019-07-22 |
558,035 |
Premium* |
|
|
Inozyme Pharma, Inc. |
INZY |
10% Owner |
2020-07-28 |
0 |
2020-07-28 |
520,125 |
Premium* |
|
|
Icosavax, Inc. |
ICVX |
10% Owner |
2021-08-02 |
0 |
2021-08-02 |
3,155,169 |
Premium* |
|
|
Translate Bio, Inc. |
TBIO |
10% Owner |
2021-09-14 |
75,668,031 |
2021-09-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
85 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2015-01-22 |
4 |
B |
$9,317.00 |
$1,828,470,567 |
I/I |
196,251 |
9,307,037 |
1.5 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2015-01-26 |
4 |
B |
$95.00 |
$61,507,560 |
I/I |
647,448 |
9,954,485 |
1.5 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2015-01-29 |
4 |
B |
$95.00 |
$9,226,210 |
I/I |
97,118 |
10,051,603 |
1.5 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
10% Owner |
– – • |
2015-07-27 |
4 |
AB |
$530.71 |
$5,718,272 |
I/I |
10,639 |
22,869,783 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
10% Owner |
– – • |
2015-09-23 |
4 |
B |
$523.43 |
$78,708,570 |
I/I |
147,209 |
23,016,992 |
1.5 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
10% Owner |
– – • |
2015-10-06 |
4 |
B |
$470.41 |
$5,214,519 |
I/I |
11,040 |
23,108,570 |
1.5 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
10% Owner |
– – • |
2015-10-06 |
4 |
B |
$449.14 |
$37,024,197 |
I/I |
80,538 |
23,097,530 |
1.5 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Former 10% owner |
– – – |
2015-11-10 |
4 |
A |
$0.00 |
$0 |
I/I |
2,352,941 |
2,352,941 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Former 10% owner |
– – – |
2015-11-16 |
4 |
B |
$14.00 |
$1,750,000 |
I/I |
125,000 |
2,477,941 |
0.01 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
10% Owner |
– – • |
2016-01-12 |
4 |
B |
$453.89 |
$39,034,660 |
I/I |
83,938 |
23,192,508 |
1.5 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2016-02-01 |
4 |
B |
$69.75 |
$14,300,843 |
I/I |
205,030 |
10,256,633 |
1.5 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
|
• • • |
2016-02-16 |
4 |
B |
$387.43 |
$31,751,182 |
I/I |
81,157 |
23,273,665 |
0.01 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
|
• • • |
2016-02-17 |
4 |
B |
$390.14 |
$31,496,728 |
I/I |
80,000 |
23,353,665 |
0.01 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
10% Owner |
– – • |
2016-06-14 |
4 |
B |
$361.44 |
$23,552,859 |
I/I |
64,731 |
23,418,396 |
1.5 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
|
• • • |
2017-01-11 |
4 |
B |
$362.47 |
$32,274,872 |
I/I |
87,298 |
23,505,694 |
2.64 |
- |
|
| ALNY |
Alnylam Pharmaceuticals I... |
10% Owner |
– – • |
2017-05-31 |
4 |
B |
$71.87 |
$21,381,397 |
I/I |
297,501 |
10,554,134 |
1.5 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
|
• • • |
2017-06-02 |
4 |
B |
$466.38 |
$65,055,558 |
I/I |
136,050 |
23,641,744 |
2.64 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
|
• • • |
2017-08-23 |
4 |
B |
$475.97 |
$29,024,050 |
I/I |
60,595 |
23,702,339 |
2.64 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
|
• • • |
2017-08-24 |
4 |
B |
$474.86 |
$51,009,572 |
I/I |
105,820 |
23,808,159 |
2.64 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
|
• • • |
2017-08-25 |
4 |
B |
$479.19 |
$34,840,133 |
I/I |
72,378 |
23,880,537 |
2.64 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
|
• • • |
2018-06-08 |
4 |
S |
$309.31 |
$37,611,882 |
I/I |
(121,601) |
23,758,936 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
|
• • • |
2018-09-06 |
4 |
S |
$406.68 |
$42,519,249 |
I/I |
(104,552) |
23,654,384 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
|
• • • |
2019-03-08 |
4 |
S |
$412.17 |
$54,041,316 |
D/D |
(131,115) |
20,723,717 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
10% Owner |
– – • |
2019-07-22 |
4 |
B |
$16.00 |
$1,500,000 |
I/I |
93,750 |
558,035 |
1.5 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
10% Owner |
– – • |
2019-07-22 |
4 |
A |
$0.00 |
$0 |
I/I |
464,285 |
464,285 |
0 |
- |
|
85 Records found
|
|
Page 3 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
